INTEGRA LIFESCIENCES HLDGS ($IART) posted quarterly earnings results for Q4 2025 on Thursday, February 26th. The company reported earnings of $0.83 per share, beating estimates of $0.82 by $0.01. The company also reported revenue of $434,930,000, missing estimates of $438,213,868 by $-3,283,868.
You can see Quiver Quantitative's $IART stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
INTEGRA LIFESCIENCES HLDGS Insider Trading Activity
INTEGRA LIFESCIENCES HLDGS insiders have traded $IART stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $IART stock by insiders over the last 6 months:
- JEFFREY A GRAVES purchased 9,000 shares for an estimated $102,150
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
INTEGRA LIFESCIENCES HLDGS Hedge Fund Activity
We have seen 102 institutional investors add shares of INTEGRA LIFESCIENCES HLDGS stock to their portfolio, and 133 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SOLEUS CAPITAL MANAGEMENT, L.P. removed 1,440,818 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $17,894,959
- DEERFIELD MANAGEMENT COMPANY, L.P. removed 755,656 shares (-95.1%) from their portfolio in Q4 2025, for an estimated $9,385,247
- KENT LAKE PR LLC added 752,086 shares (+inf%) to their portfolio in Q3 2025, for an estimated $10,777,392
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 615,637 shares (-75.8%) from their portfolio in Q4 2025, for an estimated $7,646,211
- QUANTINNO CAPITAL MANAGEMENT LP added 601,738 shares (+250.4%) to their portfolio in Q4 2025, for an estimated $7,473,585
- NEUBERGER BERMAN GROUP LLC added 541,996 shares (+35.3%) to their portfolio in Q4 2025, for an estimated $6,731,590
- INVENOMIC CAPITAL MANAGEMENT LP added 463,729 shares (+78.3%) to their portfolio in Q4 2025, for an estimated $5,759,514
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
INTEGRA LIFESCIENCES HLDGS Analyst Ratings
Wall Street analysts have issued reports on $IART in the last several months. We have seen 0 firms issue buy ratings on the stock, and 2 firms issue sell ratings.
Here are some recent analyst ratings:
- Citigroup issued a "Sell" rating on 10/31/2025
- JP Morgan issued a "Underweight" rating on 10/31/2025
To track analyst ratings and price targets for INTEGRA LIFESCIENCES HLDGS, check out Quiver Quantitative's $IART forecast page.
INTEGRA LIFESCIENCES HLDGS Price Targets
Multiple analysts have issued price targets for $IART recently. We have seen 4 analysts offer price targets for $IART in the last 6 months, with a median target of $13.0.
Here are some recent targets:
- Ravi Misra from Truist Securities set a target price of $13.0 on 11/03/2025
- Joanne Wuensch from Citigroup set a target price of $11.0 on 10/31/2025
- Robbie Marcus from JP Morgan set a target price of $13.0 on 10/31/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
